Vertex Pharmaceuticals

[audio+transcript] 6 Biotech Stocks to Watch Now
[audio+transcript] 6 Biotech Stocks to Watch Now
Motley Fool
Biogen
Bluebird Bio
Global Blood Therapeutics
Aimmune Therapeutics
Vertex Pharmaceuticals
Sarepta Therapeutics
Flag link:
Based On Sales Forecasts For 2018 FDA Approved Drugs, Big Pharma Not Just Focused On Blockbusters
Based On Sales Forecasts For 2018 FDA Approved Drugs, Big Pharma Not Just Focused On Blockbusters
Forbes
Big Pharma
Pfizer
Merck
AstraZeneca
Gilead Sciences
Alexion
Vertex Pharmaceuticals
Flag link:
Cystic fibrosis patients lobby Vertex to drop drug prices
Cystic fibrosis patients lobby Vertex to drop drug prices
Pharmaforum
Vertex Pharmaceuticals
cystic fibrosis
drug pricing
patients
Flag link:
Vertex sharpens focus on gene-editing in licensing deal with Merck KGaA
Vertex sharpens focus on gene-editing in licensing deal with Merck KGaA
Endpoints
Vertex Pharmaceuticals
Merck KGaA
gene editing
M9831
Flag link:
High-ranking Vertex exec fired over code of conduct violations
High-ranking Vertex exec fired over code of conduct violations
BioPharma Dive
Vertex Pharmaceuticals
Ian Smith
misconduct
Flag link:
3 Biotechs With Potential Blockbusters Near the Finish Line
3 Biotechs With Potential Blockbusters Near the Finish Line
Motley Fool
Vertex Pharmaceuticals
VX-659 + tezacaftor + ivacaftor
Celgene
JCAR017
Novo Nordisk
semaglutide
Flag link:
[video+transcript] Gene-Editing Stocks Took Stutter Steps Forward in 2018
[video+transcript] Gene-Editing Stocks Took Stutter Steps Forward in 2018
Motley Fool
gene editing
Editas
Vertex Pharmaceuticals
CRISPR Therapeutics
Sangamo BioSciences
Flag link:
5 Top Drug/Biotech Merger & Acquisition Targets for 2019
5 Top Drug/Biotech Merger & Acquisition Targets for 2019
Yahoo/Zacks.com
M&A
Biomarin
Vertex Pharmaceuticals
Incyte
Alnylam
Alexion
Flag link:
European Commission Approves Kalydeco to Treat Cystic Fibrosis
European Commission Approves Kalydeco to Treat Cystic Fibrosis
CP Wire
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Europe
Flag link:
European Commission Approves Kalydeco to Treat Cystic Fibrosis
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Flag link:
Vertex cystic fibrosis drug combination shows strong results in pivotal clinical trials
Vertex cystic fibrosis drug combination shows strong results in pivotal clinical trials
Stat
Vertex Pharmaceuticals
cystic fibrosis
clinical trials
VX-659 + tezacaftor + ivacaftor
Flag link:
Vertex Pharmaceuticals Waits to Hit the Triple
Vertex Pharmaceuticals Waits to Hit the Triple
Motley Fool
Vertex Pharmaceuticals
earnings
Flag link:
AbbVie Takes Aim at Vertex Pharmaceuticals Incorporated
AbbVie Takes Aim at Vertex Pharmaceuticals Incorporated
Motley Fool
AbbVie
Vertex Pharmaceuticals
cystic fibrosis
Flag link:
Vertex Receives Positive Opinion from CHMP for Kalydeco in Patients 12 to 24 months wth Cystic Fibrosis
Vertex Receives Positive Opinion from CHMP for Kalydeco in Patients 12 to 24 months wth Cystic Fibrosis
CP Wire
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Flag link:
Vertex Receives Positive Opinion from CHMP for Kalydeco in Patients 12 to 24 months wth Cystic Fibrosis
Vertex Pharmaceuticals
Kalydeco
Flag link:
CRISPR Therapeutics, Vertex Get FDA Green Light for Sickle Cell Test
CRISPR Therapeutics, Vertex Get FDA Green Light for Sickle Cell Test
Xconomy
CRISPR Therapeutics
Vertex Pharmaceuticals
sickle cell disease
FDA
CTX001
Flag link:
3 Biotech Stocks With Virtual Monopolies
3 Biotech Stocks With Virtual Monopolies
Motley Fool
Alexion Pharmaceuticals
Biomarin
Vertex Pharmaceuticals
Flag link:
Vertex Completes Enrollment of Two Ph III Studies of Cystic Fibrosis Drug Combination
Vertex Completes Enrollment of Two Ph III Studies of Cystic Fibrosis Drug Combination
CP Wire
Vertex Pharmaceuticals
VX-659
VX-445
correctors
cystic fibrosis
Flag link:
Vertex Completes Enrollment of Two Ph III Studies of Cystic Fibrosis Drug Combination
Vertex Pharmaceuticals
VX-659
VX-445
cystic fibrosis
Flag link:
Amarin Corporation, CRISPR Therapeutics, and Geron Corporation could all see big gains next week
Amarin Corporation, CRISPR Therapeutics, and Geron Corporation could all see big gains next week
Motley Fool
Amarin
CRISPR Therapeutics
Geron
Vascepa
Vertex Pharmaceuticals
CTX001
JNJ
imetelstat
Flag link:

Pages